Patients Undergoing Laparoscopic Sleeve Gastrectomy.
Conditions
Interventions
Intervention 1: Intervention group: Intraperitoneal lavage with 30 ml of 0.25% bupivacaine without normal saline. Intervention 2: Intervention group: Intraperitoneal lavage with 30 ml of 10% magnesium
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: ASA physiological status I-II Body mass index between 30 and 45 Informed consent to participate in the study
Exclusion criteria
Exclusion criteria: Patients with known allergies to bupivacaine or magnesium sulfate Long-term use of NSAIDs or other painkillers for chronic pain Patients with established hepatic or renal disorders Patients with previous heart surgery Left ventricular ejection fraction less than 40% myocardial infarction recorded in the past six weeks Congestive heart failure Patients with chronic abdominal or pelvic pain syndrome Patient with known hypermagnesemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative surgical site pain. Timepoint: 1, 2, 4, 6, 12 and 24 hours after surgery. Method of measurement: Using the VAS scale.;Shoulder pain after surgery. Timepoint: 2,6,12,24,48 hours after surgery. Method of measurement: Using the VAS scale.;Number of times the patient requested painkillers. Timepoint: The first 24 hours after surgery. Method of measurement: Counting the number of requests.;Nausea and vomiting after surgery. Timepoint: The first 24 hours after surgery. Method of measurement: have or does not have. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehzad Imani
Hamedan University of Medical Sciences
Outcome results
None listed